HOME > 感染症[業績]

感染症[業績]

呼吸不全・睡眠呼吸障害　｜　間質性肺疾患　｜　COPD　｜　喘息・慢性咳嗽　｜　感染症　｜　肺がん　｜　iPS
  • 2023年度
    1. Kataoka Y, Tanabe N, Shirata M, Hamao N, Oi I, Maetani T, Shiraishi Y, Hashimoto K, Yamazoe M, Shima H, Ajimizu H, Oguma T, Emura M, Endo K, Hasegawa Y, Mio T, Shiota T, Yasui H, Nakaji H, Tsuchiya M, Tomii K, Hirai T, Ito I. Artificial intelligence-based analysis of the spatial distribution of abnormal computed tomography patterns in SARS-CoV-2 pneumonia: association with disease severity. Respir Res 2024;25:24.
    2. Hirai T, Asano K, Ito I, Miyazaki Y, Sugiura H, Agirbasli M, Kobayashi S, Kobayashi M, Shimada D, Natsume I, Kawasaki T, Ohba T, Tajiri S, Sakamaki F, Mineshita M, Takihara T, Sekiya K, Tomii K, Tomioka H, Kita H, Nishizaka Y, Fukui M, Miyata T, Harigae H. A randomized double-blind placebo-controlled trial of an inhibitor of plasminogen activator inhibitor-1 (TM5614) in mild to moderate COVID-19. Sci Rep 2024;14:165.
    3. Morimoto C, Matsumoto H, Nomura N, Sunadome H, Nagasaki T, Sato S, Sato A, Oguma T, Ito I, Kogo M, Tomii K, Tajiri T, Ohashi K, Tsukahara T, Hirai T. Sputum microbiota and inflammatory subtypes in asthma, COPD, and its overlap. J Allergy Clin Immunol Glob 2023;3:100194.
    4. Shirata M, Nishioka K, Hamao N, Oi I, Hidaka Y, Ibi Y, Imai S, Sato S, Hirai T, Ito I. Impact of wearing a surgical facemask during exercise on dyspnea in patients with chronic pulmonary infections: a randomized crossover study. Respir Med 2023 Dec;220:107453.
    5. Nishikawa A, Ito I, Yonezawa A, Itohara K, Matsubara T, Sato Y, Matsumura K, Hamada S, Tanabe N, Kai S, Imoto E, Yoshikawa K, Ohtsuru S, Yanagita M, Hirai T, Terada T. Pharmacokinetics of GS-441524, the active metabolite of remdesivir, in patients receiving continuous renal replacement therapy: A case series. J Infect Chemother 2023 Oct 21:S1341-321X(23)00260-X E-pub ahead of print.
    6. Ito I. Have clinical studies on COVID-19 matured? Respir Investig 2023;61:800-1.
    7. Shirata M, Ito I, Oguma T, Nagasaki T, Oi I, Hamao N, Nishioka K, Hirai T. Effect of biologic therapy on the humoral immune response to the BNT162b2 vaccine in patients with asthma. Respir Investig 2023;61:733-7.
    8. Shirata M, Ito I, Tanaka M, Murata K, Murakami K, Ikeda H, Oi I, Hamao N, Nishioka K, Hayashi Y, Nagao M, Hashimoto M, Ito H, Ueno H, Morinobu A, Hirai T. Impact of methotrexate on humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis. Clin Exp Med 2023;23:4707-20.
    9. Sakai M, Ohno Y, Kozuki N, Kawasaki Y, Yoshida M, Ikeda H, Konishi J, Maeda T, Sugano M, Kawakami S, Ito I, Yamaguchi A, Naiki H, Notohara K, Akamizu T, Kawano M, Yoshida H. A Case of IgG4–related Retroperitoneal Fibrosis and Hypophysitis with Antecedent Respiratory Disease followed by Spontaneous Remission and Recurrence. Modern Rheumatol Case Rep 2023;8:163-71.
    10. Shirata M, Ito I, Jo T, Iwao T, Oi I, Hamao N, Nishioka K, Yamana H, Nagase T, Yasunaga H, Hirai T. Factors Associated With the Development of Bacterial Pneumonia Related to Seasonal Influenza Virus Infection: A Study Using a Large-scale Health Insurance Claim Database. Open Forum Infect Dis 2023;10:ofad222.
    11. Matsumoto M, Ito I, Kadowaki S. Drug-induced interstitial lung disease due to over-the-counter cold medicine taken daily for 25 years: a case report. J Med Case Rep 2023;17:83.
      口頭発表（学会発表、シンポジウム、一般演題等）
      Norihiro Jikuya, Isao Ito, Kensuke Nishioka, Masahiro Shirata, Nobuyoshi Hamao, Issei Oi, Seiichiro Imai, Tadashi Ishida, Akihiro Ito, Keisuke Tomii, Kazuo Endo, Toyohiro Hirai. Differences in clinical features between SARS-CoVCoV-2 pneumonia and Streptococcus pneumoniae pneumonia. The 27th Congress of the Asian Pacific Society of Respirology (APSR), 2023.11.18 Singapore
    2022年度
    1. Oi I, Ito I, Tanabe N, Konishi S, Hamao N, Shirata M, Imai S, Yasutomo Y, Kadowaki S, Matsumoto H, Hidaka Y, Morita S, Hirai T: Protein C activity as a potential prognostic factor for nursing home-acquired pneumonia. PLoS One. 2022;17(10):e0274685.
    2. Minami T, Kai S, Tanaka T, Ito I, Kato G, Nagao M, Date H, Hirai T, Ohtsuru S, Chin K. Non-invasive ventilation using a novel ventilator and non-vented full-face mask for patients with respiratory failure during the COVID-19 pandemic: Report of three cases. Respir Investig 2022;60:607-11.
    3. Imamura Y, Miyazaki T, Watanabe A, Tsukada H, Nagai H, Hasegawa Y, Tomono K, Ito I, Teramoto S, Ishida T, Kadota JI, Kohno S, Mukae H. Prospective multicenter survey for Nursing and Healthcare-associated Pneumonia in Japan. J Infect Chemother 2022;28:1125-30.
    4. Kohara J, Kai S, Hashimoto K, Takatani Y, Tanabe N, Hamada S, Cho K, Tanaka T, Ito I, Ohtsuru S. Successful lung-protective ventilatory management during the VV-ECMO in a severe COVID-19 pneumonia patient with extensive pneumomediastinum and subcutaneous emphysema: a case report. JA Clin Rep 2022;8:12.
    5. Sukeishi A, Itohara K, Yonezawa A, Sato Y, Matsumura K, Katada Y, Nakagawa T, Hamada S, Tanabe N, Imoto E, Kai S, Hirai T, Yanagita M, Ohtsuru S, Terada T, Ito I. Population Pharmacokinetic Modeling of GS-441524, the Active Metabolite of Remdesivir, in Japanese COVID-19 Patients with Renal Dysfunction. CPT Pharmacometrics Syst Pharmacol 2022;11:94-103.
    6. Imai S, Ito I, Hirai T. Pulmonary Mycobacterium shimoidei Infection: A Case Report and Review of Japanese Literature. Kekkaku 2022;97:345-41.
    2021年度
    1. Oi I, Ito I, Hirabayashi M, Endo K, Emura M, Kojima T, Tsukao H, Tomii K, Nakagawa A, Otsuka K, Akai M, Oi M, Sugita T, Fukui M, Inoue D, Hasegawa Y, Takahashi K, Yasui H, Fujita K, Ishida T, Ito A, Kita H, Kaji Y, Tsuchiya M, Tomioka H, Yamada T, Terada S, Nakaji H, Hamao N, Shirata M, Nishioka K, Yamazoe Y, Shiraishi Y, Ogimoto T, Hosoya K, Ajimizu H, Shima H, Matsumoto H, Tanabe N, Hirai T: Pneumonia Caused by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza Virus: A Multicenter Comparative Study. Open Forum Infect Dis. 2021; 8: ofab282.
    2. Shirata M, Ito I, Hirai T: Assessment of anti-influenza drug prescriptions for postexposure prophylaxis against household transmission of influenza virus. Clin Infect Dis. 2021;73(7):e1766.
    3. Shirata M, Ito I, Tanabe N, Konishi S, Oi I, Hamao N, Matsumoto H, Yasutomo Y, Kadowaki S, Hirai T: Risk factors associated with methicillin-resistant Staphylococcus aureus isolation from serially collected sputum samples of patients hospitalized with pneumonia. J Infect Chemother. 27(9). 1323-1328. 2021.
    4. Shirata M, Ito I, Ishida T, Tachibana H, Tanabe N, Konishi S, Oi I, Hamao N, Nishioka K, Matsumoto H, Yasutomo Y, Kadowaki S, Ohnishi H, Tomioka H, Nishimura T, Hasegawa Y, Nakagawa A, Hirai T: Development and validation of a new scoring system for prognostic prediction of community-acquired pneumonia in older adults. Sci Rep. 11(1). 2021.
    5. Yamada H, Ohtsuru S, Nagatomo M, Korogi Y, Shinozuka K, Tanabe N, Kai S, Matsubara T, Ito I, Ihara M, Tanaka T, Kato G, Nagao M, Date H. Successful treatment of COVID-19-related acute respiratory distress syndrome with a rare blood type: A case report. Clinical Case Reports 2021;9:e04859.
    6. Yoshida H, Takahashi N, Horiguchi T, Yasuhara H, Tanaka T, Chen Y, Takasaki T, Tsukao H, Yoshida M, Kawakami S, Ohta M, Naiki H, Konishi S, Ito I, Iwano M. Development of Myeloperoxidase Anti-neutrophil Cytoplasmic Antibody-positive Necrotizing Crescentic Glomerulonephritis in an Elderly Patient with Immunological Kidney Disease. Intern Med 2021;60:3927-3935.
    2020年度
    1. Shirata M, Ito I, Hirai T. Assessment of anti-influenza drug prescriptions for post-exposure prophylaxis against household transmission of influenza virus. Clin Infect Dis 2021 Jan 2. Online ahead of print.
    2. Tanabe N, Matsumoto H, Hamada S, Ito I, Hirai T. Dupilumab maintenance therapy in an asthmatic patient with coronavirus disease 2019 pneumonia. Allergol Int 2020 Nov 7:S1323-8930(20)30143-X. Online ahead of print.
    3. Hamao N, Ito I, Konishi S, Tanabe N, Shirata M, Oi I, Tsukino M, Matsumoto H, Yasutomo Y, Kadowaki S, Hirai T. Comparison of ceftriaxone plus macrolide and ampicillin/sulbactam plus macrolide in treatment for patients with community-acquired pneumonia without risk factors for aspiration: an open-label, quasi-randomized, controlled trial. BMC Pulm Med 2020;20:160.
    4. Ito A, Ito I, Inoue D, Marumo S, Ueda T, Nakagawa H, Taki M, Nakagawa A, Tatsumi S, Nishimura T, Shiota T, Ishida T. The utility of serial procalcitonin measurements in addition to pneumonia severity scores in hospitalized community-acquired pneumonia: A multicentre, prospective study. Int J Infect Dis 2020 Jan 22;92:228-233.
    5. Iwao T, Kato G, Ito I, Aramaki E, Kuroda T. A survey of clarithromycin monotherapy and long-term administration of ethambutol for patients with MAC lung disease in Japan: A retrospective cohort study using the database of health insurance claims. Pharmacoepidemiol Drug Saf 2020;29:427-32.
    6. Iwao T, Kato G, Ito I, Hirai T, Kuroda T. Treatment of Mycobacterium avium-intracellulare complex lung disease in the real world: a retrospective big data analysis. Drugs & Therapy Perspectives 2020;36:75-82.
    7. Oi I, Ito I, Tanabe N, Konishi S, Hamao N, Yasutomo Y, Kadowaki S, Hirai T. Cefepime vs. meropenem for moderate-to-severe pneumonia in patients at risk for aspiration: An open-label, randomized study. J Infect Chemother 2020;26:181-7.
    2019年
    1. Cui S, Ito I, Nakaji H, Iwata T, Matsumoto H, Oguma T, Tajiri T, Nagasaki T, Kanemitsu Y, Izuhara H, Mishima M, Niimi A. Induction of airway remodeling and persistent cough by repeated citric acid exposure in a guinea pig cough model. Respir Physiol Neurobiol 2019;263:1-8.
    2. Suzuki K, Kondo K, Washio M, Kan S, Imai S, Yoshimura K, Ota C, Ohfuji S, Fukushima W, Hirota Y, Nakashima K. Preventive effects of pneumococcal and influenza vaccines on community-acquired pneumonia in older individuals in Japan: a case-control study. Human Vaccines & Immunotherapeutics 2019;15 e-pub ahead of print.
    3. Shirata M, Tamaru A, Marumo S, Fukui M．Mycobacterium triplex pulmonary disease in an immunocompetent host: A case report and literature review. IDCases. 2019;18:e00648.
    4. Oi I, Ito I, Tanabe N, Konishi S, Hamao N, Yasutomo Y, Kadowaki S, Hirai T. Cefepime vs. meropenem for moderate-to-severe pneumonia in patients at risk for aspiration: An open-label, randomized study. J Infect Chemother 2020;26:181-7. 2020.
    5. Suzuki K, Kondo K, Washio M, Kan S, Imai S, Yoshimura K, Ota C, Ohfuji S, Fukushima W, Hirota Y, Nakashima K: Preventive effects of pneumococcal and influenza vaccines on community-acquired pneumonia in older individuals in Japan: a case-control study. Hum Vaccin Immunother 2019;15:2171-7.
    6. Iemura-Kashiwagi M, Ito I, Ikeguchi R, Kadoya M, Iemura T, Yoshida S, Suzuki K, Hirai T. Soft tissue infection caused by Mycolicibacter kumamotonensis. J Infect Chemother 2020;26:136-9.
    7. Cui S, Ito I, Nakaji H, Iwata T, Matsumoto H, Oguma T, Tajiri T, Nagasaki T, Kanemitsu Y, Izuhara H, Mishima M, Niimi A. Induction of airway remodeling and persistent cough by repeated citric acid exposure in a guinea pig cough model. Respir Physiol Neurobiol 2019;263:1-8.
    2018年
    1. Horie H, Ito I, Konishi S, Yamamoto Y, Yamamoto Y, Uchida T, Ohtani H, Yoshida Y. Isolation of ESBL-producing bacteria from sputum in community-acquired pneumonia or healthcare-associated pneumonia does not indicate the need for antibiotics with activity against this class. Intern Med 2018;57:487-95.
    2. Imai-Matsushima A, Martin-Sancho L, Karlas A, Imai S, Zoranovic T, Hocke AC, Mollenkopf HJ, Berger H, Meyer TF: Long-Term Culture of Distal Airway Epithelial Cells Allows Differentiation Towards Alveolar Epithelial Cells Suited for Influenza Virus Studies. EBioMedicine 2018;33:230-41.
    2017年
    1. Matsuda Y, Chigusa Y, Kondoh E, Ito I, Ueda Y, Mandai M. A case of macrolide-refractory Mycoplasma pneumoniae pneumonia in pregnancy treated with Garenoxacin. Case Reports in Obsterics and Gynecology 2017; article ID 3520192
    2. Inoue H, Ito I, Niimi A, Matsumoto H, Oguma T, Tajiri T, Iwata T, Nagasaki T, Kanemitsu Y, Morishima T, Hirota T, Tamari M, Wenzel SE, Mishima M. Association of interleukin 1 receptor-like 1 gene polymorphisms with eosinophilic phenotype in Japanese adults with asthma. Respir Investig 2017;55:338-347.
    3. Kamada T, Ito I, Kanemitsu Y, Sato S, Matsumoto H, Niimi A, Mishima M. Three-dimensional imaging forced oscillation technique to assess position-dependent airway obstruction in relapsing polychondritis; a case report. Respir Investig 2017;55:69-73.
    2016年
    1. Ebisutani C, Ito I, Kitaichi M, Tanabe N, Mishima M, Kadowaki S. A case of non-specific interstitial pneumonia with recurrent gastric carcinoma and anti-Jo-1 antibody positive myositis. Respir Investig 2016;54:289-93.
    2. Inoue H, Ito I, Niimi A, Matsumoto H, Matsuoka H, Jinnai M, Takeda T, Oguma T, Otsuka K, Nakaji H, Tajiri T, Iwata T, Nagasaki T, Kanemitsu Y, Mishima M. CT-assessed large airway involvement and lung function decline in eosinophilic asthma: The association between induced sputum eosinophil differential counts and airway remodeling. J Asthma. 2016;53:914-21.
    3. Fujita K, Fujita M, Ito Y, Hirai T, Mio T, Watanabe K, Mishima M. Preliminary Evaluation of a Sitafloxacin-Containing Regimen for Relapsed or Refractory Pulmonary Mycobacterium avium Complex Disease. Open Forum Infect Dis. 2016;3:ofw147.
    4. Hamada S, Ito Y, Hirai T, Murase K, Tsuji T, Fujita K, Mio T, Maekawa K, Fujii T, Ono S, Nishimura T, Hayashi A, Komori T, Fujita N, Niimi A, Ichiyama S, Chin K, Mishima M. Impact of industrial structure and soil exposure on the regional variations in pulmonary nontuberculous mycobacterial disease prevalence. Int J Mycobacteriol 2016;5:170-6.
    5. Ito Y, Nagao M, Iinuma Y, Matsumura Y, Yamamoto M, Takakura S, Igawa J, Yamanaka H, Hashimoto A, Hirai T, Niimi A, Ichiyama S, Mishima M. Risk factors for nosocomial tuberculosis transmission among health care workers. Am J Infect Control 2016;44:596-8.
    6. 伊藤功朗著．「肺炎の診かた，考えかた」中外医学社　2016年4月．
    2015年
    1. Ito Y, Hirai T, Fujita K, Maekawa K, Niimi A, Ichiyama S, Mishima M. Increasing patients with pulmonary Mycobacterium avium complex disease and associated underlying diseases in Japan. J Infect Chemother. 2015;21:352-6.
    2. Iwata T, Ito I, Niimi A, Ikegami K, Marumo S, Tanabe N, Nakaji H, Kanemitsu Y, Matsumoto H, Kamei J, Setou M, Mishima M. Mechanical Stimulation by Postnasal Drip Evokes Cough. PLoS One. 2015;10:e0141823.
    2014年
    1. Gotoh S, Ito I, Nagasaki T, Yamamoto Y, Konishi S, Korogi Y, Matsumoto H, Muro S, Hirai T, Funato M, Mae S, Toyoda T, Sato-Otsubo A, Ogawa S, Osafune K, Mishima M. Generation of alveolar epithelial spheroids via isolated progenitor cells from human pluripotent stem cells. Stem Cell Reports 2014;3:394-403.
    2. Ito I, Mishima M. Isolation of drug-resistant pathogens does not always require use of broad-spectrum antibiotics in pneumonia. Am J Respir Crit Care Med 2014;189:756-7.
    3. Ito Y, Hirai T, Fujita K, Kubo T, Maekawa K, Ichiyama S, Togashi K, Mishima M. The influence of environmental exposure on the response to antimicrobial treatment in pulmonary Mycobacterial avium complex disease. BMC Infect Dis. 2014;14:522
    4. Fujita K, Ito Y, Hirai T, Kubo T, Maekawa K, Togashi K, Ichiyama S, Mishima M.　Association between polyclonal and mixed mycobacterial Mycobacterium avium complex infection and environmental exposure.　Ann Am Thorac Soc. 2014;11:45-53.
    5. Fujita K, Ito Y, Hirai T, Kubo T, Togashi K, Ichiyama S, Mishima M.Prevalence and risk factors for chronic co-infection in pulmonary Mycobacterium avium complex disease.　BMJ Open Respir Res. 2014;1:e000050.
    2013年
    1. Maekawa K, Ito Y, Oga T, Hirai T, Kubo T, Fujita K, Imai S, Niimi A, Chin K, Ichiyama S, Togashi K, Mishima M. High-resolution computed tomography and health-related quality of life in Mycobacterium avium complex disease. Int J Tuberc Lung Dis. 2013;17:829-35.
    2. Fujita K, Ito Y, Hirai T, Maekawa K, Imai S, Tatsumi S, Niimi A, Iinuma Y, Ichiyama S, Mishima M. Genetic relatedness of Mycobacterium avium-intracellulare complex isolates from patients with pulmonary MAC disease and their residential soils. Clin Microbiol Infect. 2013;19:537-41.
      2012年
    3. Ito Y, Hirai T, Maekawa K, Fujita K, Imai S, Tatsumi S, Handa T, Matsumoto H, Muro S, Niimi A, Mishima M. Predictors of 5-year mortality in pulmonary Mycobacterium avium-intracellulare complex disease. Int J Tuberc Lung Dis. 2012;16:408-14.
    4. Imai S, Ito Y, Hirai T, Imai H, Ito I, Maekawa K, Chin K, Ichiyama S, Uemoto S, Mishima M. Clinical features and risk factors of tuberculosis in living-donor liver transplant recipients. Transpl Infect Dis. 2012;14:9-16.
    5. Matsumura Y, Ito Y, Iinuma Y, Yasuma K, Yamamoto M, Matsushima A, Nagao M, Takakura S, Ichiyama S. Quantitative real-time PCR and the (1→3)-β-D-glucan assay for differentiation between Pneumocystis jirovecii pneumonia and colonization. Clin Microbiol Infect. 2012;18:591-7.
      2011年
    6. Hamada S, Ito Y, Imai S, Oguma T, Niimi A, Mishima M. Effect of inhaled corticosteroid therapy on CT scan-estimated airway dimensions in a patient with chronic bronchitis related to ulcerative colitis. Chest. 2011;139:930-2.
    7. Maekawa K, Ito Y, Hirai T, Kubo T, Imai S, Tatsumi S, Fujita K, Takakura S, Niimi A, Iinuma Y, Ichiyama S, Togashi K, Mishima M. Environmental risk factors for pulmonary Mycobacterium avium-intracellulare complex disease. Chest. 2011;140:723-9.
    8. Imai S, Ito Y, Ishida T, Hirai T, Ito I, Yoshimura K, Maekawa K, Takakura S, Niimi A, Iinuma Y, Ichiyama S, Mishima M; Kansai Community Acquired Pneumococcal Pneumonia Study Group. Distribution and clonal relationship of cell surface virulence genes among Streptococcus pneumoniae isolates in Japan. Clin Microbiol Infect. 2011;17:1409-14.
    9. Takeda N, Nojima T, Terao C, Yukawa N, Kawabata D, Ohmura K, Usui T, Fujii T, Ito Y, Iinuma Y, Mimori T. Interferon-gamma release assay for diagnosing Mycobacterium tuberculosis infections in patients with systemic lupus erythematosus. Lupus. 2011;20:792-800.
      2010年
    10. Osawa M, Ito Y, Ishida T, Imai S, Ichiyama S, Mishima M; Kansai Community Acquired Pneumococcal Pneumonia Study Group.Molecular characterization of quinolone resistance-determining regions and their correlation with serotypes and genotypes among Streptococcus pneumoniae isolates in Japan. Eur J Clin Microbiol Infect Dis. 2010;29:245-8.
      2009年
    11. Imai S, Ito Y, Ishida T, Hirai T, Ito I, Maekawa K, Takakura S, Iinuma Y, Ichiyama S, Mishima M; Kansai Community Acquired Pneumococcal Pneumonia Study Group. High prevalence of multidrug-resistant Pneumococcal molecular epidemiology network clones among Streptococcus pneumoniae isolates from adult patients with community-acquired pneumonia in Japan. Clin Microbiol Infect. 2009;15:1039-45
      2008年
    12. Isozumi R, Ito Y, Ishida T, Hirai T, Ito I, Maniwa K, Hayashi M, Kagioka H, Hirabayashi M, Onaru K, Tomioka H, Tomii K, Gohma I, Osawa M, Imai S, Takakura S, Iinuma Y, Chin K, Ichiyama S, Mishima M; Kansai Community Acquired Pneumococcal Pneumonia Study Group. Molecular characteristics of serotype 3 Streptococcus pneumoniae isolates among community-acquired pneumonia patients in Japan. J Infect Chemother. 2008;14:258-61
    13. Ishida T, Maniwa K, Kagioka H, Hirabayashi M, Onaru K, Tomioka H, Hayashi M, Tomii K, Gohma I, Ito Y, Hirai T, Ito I, Mishima M. Antimicrobial susceptibilities of Streptococcus pneumoniae isolated from adult patients with community-acquired pneumonia in Japan. Respirology. 2008;13:240-246.
      2007年
    14. Ito Y, Osawa M, Isozumi R, Imai S, Ito I, Hirai T, Ishida T, Ichiyama S, Mishima M; Kansai Community Acquired Pneumococcal Pneumonia Study Group. Pneumococcal surface protein A family types of Streptococcus pneumoniae from community-acquired pneumonia patients in Japan. Eur J Clin Microbiol Infect Dis. 2007;26:739-42.
    15. Osawa M, Ito Y, Hirai T, Isozumi R, Takakura S, Fujimoto Y, Iinuma Y, Ichiyama S, Tanaka K, Mishima M. Risk factors for invasive aspergillosis in living donor liver transplant recipients. Liver Transpl. 2007; 13:566-70.
    16. Isozumi R, Ito Y, Ishida T, Osawa M, Hirai T, Ito I, Maniwa K, Hayashi M, Kagioka H, Hirabayashi M, Onari K, Tomioka H, Tomii K, Gohma I, Imai S, Takakura S, Iinuma Y, Ichiyama S, Mishima M; Kansai Community Acquired Pneumococcal Pneumonia Study Group. Genotypes and related factors reflecting macrolide resistance in pneumococcal pneumonia infections in Japan. J Clin Microbiol. 2007; 45:1440-6.
呼吸不全・睡眠呼吸障害　｜　間質性肺疾患　｜　COPD　｜　喘息・慢性咳嗽　｜　感染症　｜　肺がん　｜　iPS